79 Views | 38 Downloads
Dr. Akanksha Agrawal, Clinical Fellow, Cardiovascular Diseases, Emory University, 101 Woodruff Circle, Suite 319, Atlanta, Georgia 30322. akanksha21agr@gmail.com; aagra30@emory.edu
Dr. Ogunniyi has received research funds to Emory; serves as a principal investigator for AstraZeneca on DELIVER; has served as a principal investigator for AstraZeneca on DAPA-HF; serves as a principal investigator for Boehringer Ingelheim on EMPERIAL-Reduced and EMPERIAL-Preserved trials; has served as a principal investigator from Alnylam on the ENDEAVOUR trial, has received pending research support (significant) and serves as a principal investigator at Duke Clinical Research Institute on COORDINATE-Diabetes; and has served as aprincipal investigator for Zoll, BMAD Treatment; and has received modest honoraria from the Cardiology Advisory Board. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
© 2020 The Authors